Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation.

[This corrects the article DOI: 10.21037/atm-21-1069.]. 2022 Annals of Translational Medicine. All rights reserved.

This article (1) titled “HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation” (doi: 10.21037/atm-21-1069), unfortunately contains an error in Figure 5, in which the wrong soft agar image was mistakenly used in the TU212/Scramble control for Figure 5A during figure assembly. Besides, the “Representational soft agar growth assay are” should be changed to “Representational soft agar growth assay is” in the legend of Figure 5. The correct Figure 5 and legend of Figure 5 can be found below.

Correct Figure 5:

Figure 5

5-hydroxytryptamine receptor 7 (HTR7) promotes laryngeal cancer growth. (A) Soft agar growth analysis of the effect of HTR7 overexpression or knockdown on cell growth. The colony size was determined using an ocular micrometer and colonies >0.1 mm in diameter were counted through a bright-field microscope under ×400 magnification. Representational soft agar growth assay is shown on the left; statistical analysis is shown on the right. (B) Animal model analysis of the effect of HTR7 overexpression or knockdown on cell growth. Representational soft agar growth assay is shown on the left; tumor volume analysis is shown on the right. Error bars represent the mean ± STDEV. *P<0.05.

The authors apologize for the oversight.

Click here to view the updated version of the article.